Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | 475.68M | 455.90M | 436.73M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 475.68M | 455.90M | 436.73M | |
| Cost of Revenue | -- | 75.17M | 73.11M | 68.24M | |
| Gross Profit | -- | 400.50M | 382.80M | 368.50M | |
| SG&A Expenses | -- | 220.15M | 211.79M | 199.23M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 409.20M | 394.50M | 374.88M | |
| Operating Income | -- | 66.48M | 61.40M | 61.86M | |
| Income Before Tax | -- | 90.68M | 84.30M | -144.52M | |
| Income Tax Expenses | -- | 12.35M | 7.97M | 6.43M | |
| Earnings from Continuing Operations | -- | 78.33 | 76.33 | -150.95 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 78.33M | 76.33M | -150.95M | |
| EBIT | -- | 66.48M | 61.40M | 61.86M | |
| EBITDA | -- | 78.35M | 72.06M | 72.43M | |
| EPS Basic | -- | 0.32 | 0.32 | -0.76 | |
| Normalized Basic EPS | -- | 0.12 | 0.11 | 0.11 | |
| EPS Diluted | -- | 0.31 | 0.31 | -0.76 | |
| Normalized Diluted EPS | -- | 0.12 | 0.10 | 0.10 | |
| Average Basic Shares Outstanding | -- | 966.40M | 954.36M | 919.56M | |
| Average Diluted Shares Outstanding | -- | 999.50M | 995.36M | 954.34M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |